News & Media

Press Releases

Apr 24, 2017
Amedica Announces Regulatory Clearance to Market and Sell Valeo(R) Silicon Nitride Spinal Implants in Australia

Australian Marketing Clearance Provides Opportunities for Global Expansion SALT LAKE CITY, UT -- (Marketwired) -- 04/24/17 -- Amedica Corporation (NASDAQ: AMDA), an innovative medical device company that develops and commercializes silicon nitride, is pleased to announce it has been granted marketing clearance for its Valeo interbody fusion devices in Australia. The Valeo product line is made entirely of Amedica's proprietary medical grade silicon nitride ceramic -- an ideal material for fusion because of its nanostructured surface, osteoconductivity, osteoinductivity, anti-microbial properties, and…

View All News

Events Calendar

Oct 9–October 11, 2017
CNS 2017 Annual Meeting

Boston, MA

View All Events

Tweets